Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus vs Tacrolimus in Hispanic Kidney Transplant Recipients
NCT03438773Phase 1Unknown
- Start
- Jul 2018
- Primary completion
- Dec 2023
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tacrolimus in kidney transplant rejection (2 arms). Primary endpoint: Tacrolimus trough drug levels at 2 years. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT03438773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03438773.